Oxeia Biopharmaceuticals, Inc., a biotechnology company, is catalyzing the development of first-in-class neurometabolic treatments for concussions and other aspects of brain injury.
from Dementia Big http://ift.tt/1VbuMkg
via Stopping Dementia
from WordPress http://ift.tt/1PHG8bG
via alcoholic dementia
http://ift.tt/1SAg7kC
No comments:
Post a Comment